Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 6Phase 1 3Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Pancreatic Adenocarcinoma 1Malignant Neoplasm in the Head and Neck 1Lung Metastases 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Ethiodized Oil × Clear all
NCT04200417 2025-05-16

Chemoembolization for Lung Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
Thoracic

Lung Metastases

NCT05490381 2023-12-12

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

University of Washington

Phase 1 Withdrawn
Head & NeckOther neoplasm

Malignant Neoplasm in the Head and Neck

NCT03865563 2020-01-27

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡